INHIBITING OF STAT-1 Russian patent published in 2007 - IPC A61K31/713 A61P29/00

Abstract RU 2311910 C2

FIELD: pharmaceuticals.

SUBSTANCE: claimed method relates to application of DNA oligonucleotide useful in inhibition of STAT-1 transcription factor to produce drug for amelioration of inflammation reactions and preventing and/or therapy of ishemic/reperfusion damages in surgery and organ transplantation, respectively.

EFFECT: therapy of increased effectiveness.

9 ex, 10 dwg

Similar patents RU2311910C2

Title	Year	Author	Number
MODULATION OF EXPRESSION OF STAT-1-DEPENDED GENES	2002	Kheker Markus Vagner Andreas Kh.	RU2311456C2
TREATING DISEASES ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) BY SUPPRESSION OF NATURAL ANTISENSE VEGF TRANSCRIPT	2009	Kollard Dzhozef Khor'Kova Sherman Ol'Ga	RU2569182C2
TREATMENT OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO BDNF	2013	Faghihi Mohammad Ali Coito Carlos	RU2661104C2
TREATMENT OF PANCREATIC DEVELOPMENTAL GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO PANCREATIC DEVELOPMENTAL GENE	2011		RU2612161C2
TREATMENT OF DISEASES CONNECTED WITH SITE-1 MEMBRANE-IMPACTED PEPTIDASE OF TRANSCRIPTION FACTORS (MBTPS1), BY INHIBITING NATURAL ANTISENSE TRANSCRIPT TO MBTPS1	2010	Kollard Dzhozef Khorkova Sherman Olga	RU2639550C2
TREATMENT OF TUMORS OF DISEASES RELATED TO THE GENOM-SUPPRESSOR BY THERAPY OF NATURAL TRANSCRIPT INHIBITION IN ANTI-SIGNIFICANT ORIENTATION REGARDING THIS GENE	2009	Kollard Dzhozef Khorkova Sherman Olga	RU2746478C2
DEEP GLYCATION END PRODUCTS RECEPTOR MODULATORS AND MODULATION	2020	Uilton, Stiven Tomas, Merlin Kristofer Rozado, Karlos Pikering, Raelen Dzhejn	RU2820247C2
TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN (SIRT)	2011	Kollard Dzhozef Khorkova Sherman Olga Kojto Karlos De Leon Belinda	RU2693462C2
TREATMENT OF TUMORS OF DISEASES RELATED TO THE GENOM-SUPPRESSOR BY THERAPY OF NATURAL TRANSCRIPT INHIBITION IN ANTI-SIGNIFICANT ORIENTATION REGARDING THIS GENE	2009	Kollard Dzhozef Khorkova Sherman Olga	RU2618688C2
TREATMENT OF DISEASES ASSOCIATED WITH SUBSTRATE OF INSULIN RECEPTOR 2 (IRS2) BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2	2010	Kollard Dzhozef Khorkova Sherman Olga	RU2616283C2

RU 2 311 910 C2

Authors

Kheker Markus

Vagner Andreas Kh.

Dates

2007-12-10—Published

2002-10-02—Filed